Skip to main content
AXTA
NYSE Industrial Applications And Services

Axalta Reports Record FY25 Adjusted EBITDA & EPS, Provides 2026 Guidance Amidst AkzoNobel Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Neutral
Importance info
7
Price
$36.19
Mkt Cap
$7.298B
52W Low
$26.28
52W High
$38.17
52W Position info
38% above low
Off High info
5.2% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AXTA sits 38% above its 52-week low of $26.28.

Summary

Axalta Coating Systems reported record full-year 2025 Adjusted EBITDA and Adjusted Diluted EPS, alongside strong cash flow and debt reduction, while providing 2026 guidance and highlighting its position for the pending merger with AkzoNobel.


Key Events · Earnings and Guidance · AXTA

  • Record Full-Year 2025 Adjusted Performance

    Achieved record Adjusted EBITDA of $1,128 million (22.0% margin) and record Adjusted Diluted EPS of $2.49, despite a 3% decrease in net sales to $5,117 million.

  • Strong Cash Flow & Balance Sheet

    Reported record cash provided by operating activities of $649 million and free cash flow of $466 million for FY25, ending the year with the lowest net debt to LTM Adjusted EBITDA ratio in company history at 2.3x.

  • Mixed Q4 2025 Results

    Fourth quarter net sales decreased 4% year-over-year to $1,262 million, with net income down significantly to $60 million, though Adjusted EBITDA margin expanded by 50 basis points to 21.5%.

  • 2026 Financial Outlook

    Provided guidance for full-year 2026, projecting low-single digit net sales decline, but anticipating Adjusted EBITDA between $1,140-$1,170 million and Adjusted Diluted EPS of $2.55-$2.70, along with over $500 million in free cash flow.


Analysis · AXTA · Industrial Applications And Services

Axalta Coating Systems delivered a robust full-year 2025 performance, achieving record Adjusted EBITDA and Adjusted Diluted EPS, driven by operational excellence and cost management despite a challenging macro environment that led to a slight decline in net sales. The company significantly strengthened its balance sheet, reaching its lowest net debt to Adjusted EBITDA ratio, and generated record cash flow, providing a solid financial foundation. While fourth-quarter net sales and GAAP net income saw declines, the improvement in Adjusted EBITDA margin indicates underlying operational efficiency. The provided 2026 guidance projects continued growth in Adjusted EBITDA and Adjusted Diluted EPS, even with anticipated revenue headwinds, suggesting management's confidence in sustained profitability. This strong financial positioning is particularly relevant as the company progresses towards its pending merger of equals with AkzoNobel, which is expected to create a premier global coatings company. Investors should monitor the integration progress and the realization of anticipated synergies post-merger.

At the time of this filing, AXTA was trading at $36.19 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.3B. The 52-week trading range was $26.28 to $38.17. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AXTA - Latest Insights

AXTA
Jul 28, 2026, 5:20 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.73
Real-time Price: $34.69 info
Change: -$0.040 (-0.12%) info
Market Cap: $7.585B info
AXTA
Jul 28, 2026, 5:19 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.73
Real-time Price: $34.69 info
Change: -$0.040 (-0.12%) info
Market Cap: $7.585B info
AXTA
Jul 28, 2026, 5:18 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $34.73
Real-time Price: $34.69 info
Change: -$0.040 (-0.12%) info
Market Cap: $7.585B info
AXTA
Jul 28, 2026, 6:08 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $34.93
Real-time Price: $34.69 info
Change: -$0.240 (-0.69%) info
Market Cap: $7.585B info
AXTA
Jul 28, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $34.93
Real-time Price: $34.69 info
Change: -$0.240 (-0.69%) info
Market Cap: $7.585B info